ArticleTheranostics2021

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.

Chengfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.